Exact Sciences Corp (NAS:EXAS)
$ 53.52 2.52 (4.94%) Market Cap: 9.88 Bil Enterprise Value: 11.78 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 78/100

Exact Sciences Corp at Robert W Baird Global Healthcare Conference (Virtual) Transcript

Sep 15, 2021 / 04:15PM GMT
Release Date Price: $104.65 (+7.82%)
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

All right, everyone. Thank you so much for joining. I'm Catherine Schulte, I cover life sciences and diagnostics here at Baird. We're very excited to have Exact Sciences here with us today. And representing the company, we have Kevin Conroy, Chairman and CEO; and Jeff Elliott, CFO and COO.

So before we begin, just a reminder to refer to Baird's website and our published research for important disclosures about what we'll be discussing today. We're just going to jump straight into Q&A. So if anyone from the audience has any questions, please submit them via the web portal, and we will work them into the conversation. So with that, Kevin, Jeff, thanks so much for joining today.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO

It's great to be here, Catherine. Thanks for having us.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot